Ascendis Pharma A (ASND) Inventory Average (2021 - 2026)

Ascendis Pharma A (ASND) has 6 years of Inventory Average data on file, last reported at $359.5 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 15.2% year-over-year to $359.5 million; the trailing twelve-month figure through Mar 2026 stood at $359.5 million (up 15.2% YoY), and the FY2025 full-year result was $335.5 million, up 22.89% from the prior year.
• Inventory Average improved to $359.5 million in Q1 2026, from $352.0 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $359.5 million in Q1 2026 to a low of $95.0 million in Q1 2022.
• A 5-year average of $231.7 million and a median of $238.8 million in 2024 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average jumped 82.55% in 2023 and climbed 15.2% in 2026, its largest moves.
• Tracing ASND's Inventory Average over 5 years: stood at $119.1 million in 2022, then jumped by 80.84% to $215.3 million in 2023, then soared by 41.03% to $303.7 million in 2024, then climbed by 15.92% to $352.0 million in 2025, then grew by 2.12% to $359.5 million in 2026.
• Business Quant data shows ASND's Inventory Average at $359.5 million in Q1 2026, $352.0 million in Q4 2025, and $348.2 million in Q3 2025.